Subscribe
Call Us: 02380 97 07 33

All Posts

Vision coming together…

Vision coming together…

by Kazeem Olalekan MRPharmS I took my daughter to the optician recently and it got me thinking: What an amazing thing: vision! We all need it and all the better if it is a good one. In October last year, I wrote a blog about the 2020 […]

Read more

Apps Updates! – MicroGuide; NICE Guidance; CPPE; NICE BNF; NICE BNFc

Apps Updates! – MicroGuide; NICE Guidance; CPPE; NICE BNF; NICE BNFc

by Kazeem Olalekan MRPharmS If you follow our blog, you will know that we are passionate about apps (you know..iphone (OS), android and possibly others – I know Microsoft is working very hard to narrow the gap on its rivals – so when we get our hands […]

Read more

Who will show clinical leadership?

Who will show clinical leadership?

by Kazeem Olalekan MRPharmS I cannot help but notice, with concern, the latest news item by in which  Boots the Chemist is to offer ‘3 for 2’ mix and match promotion across its entire healthcare range this week (link). Clearly the customer will welcome an opportunity to pay […]

Read more

Did you miss any of these?

Did you miss any of these?

by Kazeem Olalekan MRPharmS In August a number of communications on medicines safety were sent out to healthcare professionals via the MHRA. If you missed any of it then here are the summary. Full details are available on the MHRA website. Number 1: Number 2: Number 3: […]

Read more

Case Study 6: Critical Evaluation

Case Study 6: Critical Evaluation

by Kazeem Olalekan MRPharmS This July we have posted our 6th Case Study. We are quite proud about this one. Kazeem conducted an interview with Sue Gough, a Critical Evaluation Pharmacist at University Hospitals Southampton NHS Foundation Trust. It provides an insight into what these breeds of […]

Read more

Saved – The future is bright.

Saved – The future is bright.

by Kazeem Olalekan MRPharmS I was delighted by the news that the National Paediatric Surgery Reviews has opted for option B which means that University Hospital Southampton NHS Foundation Trust (UHSFT) in partnership with Oxford Radcliffe Hospitals NHS Trust will continue to deliver first class quality service […]

Read more

New MUR Requirements

New MUR Requirements

by Kazeem Olalekan MRPharmS     The latest update to MUR requirements (1) which applied from the 1st of July is refreshing. If I was commissioning the service for the first time, this is what it might look like. Nonetheless, evolution is not a bad thing. The […]

Read more

Yet another one from the nice folks at NICE – NICE BNF

Yet another one from the nice folks at NICE – NICE BNF

by Kazeem Olalekan Clearly I am excitable. When I learnt of the new iphone and Android app from the nice folks at NICE, then you know what is coming. Hee Heee Heeeeeeeeeeeeeeeeeeeeee  Haaaaaaaaaaaah! I’ll tell you why. I spent my top dollar about a year ago on […]

Read more

Febuxostat (Adenuric) and hypersensitivity reaction

Febuxostat (Adenuric) and hypersensitivity reaction

by Kazeem Olalekan Attention has just been drawn to the Drug Safety Update on Febuxostat (Adenuric) via the PJOnline website. In summary, there have been rare but serious reports of hypersensitivity reactions, including Stevens-Johnson syndrome and acute anaphylactic shock, with febuxostat (Adenuric). Febuxostat must be stopped immediately […]

Read more

Boots and Walgreens

Boots and Walgreens

by Kazeem Olalekan MRPharmS The recent acquisition of 45% stake in Boots the Chemist by US Firm, Walgreen could be viewed as another good example of the special relationship between the US and the UK. It has been reported that the two companies have very little overlap. […]

Read more

Transfer of Care – an update

Transfer of Care – an update

by Kazeem Olalekan MRPharmS The final report on the transfer of information about medicine when patients move between care setting has been published. It makes for an interesting read. The main recommendations are:     The report quoted an audit conducted in 2010 across 50 acute trusts […]

Read more

Advice for Pharmacists as Doctors strike

Advice for Pharmacists as Doctors strike

by Kazeem Olalekan The Royal Pharmaceutical Society of Great Britain has issued advice to pharmacist on how to deal with requests for emergency supplies of regular medicines. The doctors go on strike this Thursday (21st of June). The key advise are:

Read more

The results are in…and everyone is a winner

The results are in…and everyone is a winner

by Kazeem Olalekan Following from the recently completed election onto the National Pharmacy Board in England, Wales and Scotland; bookapharmacist.com is happy to note that this is an election it is proud of. Everyone is a winner: elected or not. We are releasing a YouTube video of […]

Read more

The silence of the pips

The silence of the pips

by Kazeem Olalekan The publication of the final report  into the PIP debacle, by the NHS Medical Director, should signal the ‘silence of the pips’. The report is making it clear that: This report should at least silence the pips and bring reassurance to worried patients. The […]

Read more

Urgent: (Action Required within 5 days) – MHRA Class 3 Alert: Cyclizine Lactate Injection 50mg/ 1ml ampoules

Urgent: (Action Required within 5 days) – MHRA Class 3 Alert: Cyclizine Lactate Injection 50mg/ 1ml ampoules

by Kazeem Olalekan MRPharmS Cyclizine Lactate Injection 50mg/ 1ml ampoules PL 00156/0096 Martindale Pharmaceuticals Ltd is recalling all remaining unexpired ampoules of the above discontinued product as a precautionary measure. This is due to a GMP concern at a third-party supplier and their own site. It is likely […]

Read more
Page 3 of 1212345...10...Last »

Disclaimer

The information on this site is provided 'as is' Whilst we stake our reputation on producing the most accurate information (and employ reasonable care and skill in providing this site's content), we cannot warrant that the information is accurate, complete and up to date. Neither can we guarantee uninterrupted performance and durability.
Click here to read our complete terms and conditions.